Document Detail

Neisseria gonorrhoeae antimicrobial resistance among men who have sex with men and men who have sex exclusively with women: the Gonococcal Isolate Surveillance Project, 2005-2010.
MedLine Citation:
PMID:  23460055     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Gonorrhea treatment has been complicated by antimicrobial resistance in Neisseria gonorrhoeae. Gonococcal fluoroquinolone resistance emerged more rapidly among men who have sex with men (MSM) than men who have sex exclusively with women (MSW).
OBJECTIVE: To determine whether N. gonorrhoeae urethral isolates from MSM were more likely than isolates from MSW to exhibit resistance to or elevated minimum inhibitory concentrations (MICs) of antimicrobials used to treat gonorrhea.
DESIGN: 6 years of surveillance data from the Gonococcal Isolate Surveillance Project.
SETTING: Publicly funded sexually transmitted disease clinics in 30 U.S. cities.
PATIENTS: Men with a total of 34 600 episodes of symptomatic urethral gonorrhea.
MEASUREMENTS: Percentage of isolates exhibiting resistance or elevated MICs and adjusted odds ratios for resistance or elevated MICs among isolates from MSM compared with isolates from MSW.
RESULTS: In all U.S. regions except the West, isolates from MSM were significantly more likely to exhibit elevated MICs of ceftriaxone and azithromycin than isolates from MSW (P < 0.050). Isolates from MSM had a high prevalence of resistance to ciprofloxacin, penicillin, and tetracycline and were significantly more likely to exhibit antimicrobial resistance than isolates from MSW (P < 0.001).
LIMITATIONS: Sentinel surveillance may not be representative of all patients with gonorrhea. HIV status, travel history, and antimicrobial use data were missing for some patients.
CONCLUSION: Men who have sex with men are vulnerable to the emerging threat of antimicrobial-resistant N. gonorrhoeae. Because antimicrobial susceptibility testing is not routinely done in clinical practice, clinicians should monitor for treatment failures among MSM diagnosed with gonorrhea. Strengthened prevention strategies for MSM and new antimicrobial treatment options are needed.
Robert D Kirkcaldy; Akbar Zaidi; Edward W Hook; King K Holmes; King H Holmes; Olusegun Soge; Carlos del Rio; Geraldine Hall; John Papp; Gail Bolan; Hillard S Weinstock
Related Documents :
23430175 - Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic...
23921795 - The potential of use basil and rosemary essential oils as effective antibacterial agents.
22498905 - Heterogeneity of helicobacter pylori.
23095365 - Neonatal sepsis at muhimbili national hospital, dar es salaam, tanzania; aetiology, ant...
23519865 - Differences in the antibiotic susceptibility of human escherichia coli with poultry-ass...
8390475 - Oligonucleotide probes in infectious bronchitis virus diagnosis and strain identification.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Annals of internal medicine     Volume:  158     ISSN:  1539-3704     ISO Abbreviation:  Ann. Intern. Med.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-03-05     Completed Date:  2013-05-06     Revised Date:  2014-09-20    
Medline Journal Info:
Nlm Unique ID:  0372351     Medline TA:  Ann Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  321-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Bacterial Agents / therapeutic use*
Azithromycin / therapeutic use
Ceftriaxone / therapeutic use
Ciprofloxacin / therapeutic use
Doxycycline / therapeutic use
Drug Resistance, Bacterial*
Gonorrhea / drug therapy*,  microbiology*
Logistic Models
Microbial Sensitivity Tests
Neisseria gonorrhoeae / drug effects*
Penicillins / therapeutic use
Sensitivity and Specificity
Sentinel Surveillance
Tetracycline / therapeutic use
Grant Support
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Penicillins; 5E8K9I0O4U/Ciprofloxacin; 75J73V1629/Ceftriaxone; 83905-01-5/Azithromycin; F8VB5M810T/Tetracycline; N12000U13O/Doxycycline
Erratum In:
Ann Intern Med. 2013 Sep 3;159(5):372
Note: Holmes, King H [corrected to Holmes, King K]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk a...
Next Document:  Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma: A Meta-a...